Related Experiment Video
Updated: Aug 15, 2026

11:28
Dissecting Host-virus Interaction in Lytic Replication of a Model Herpesvirus
Published on: October 7, 2011
Effect of phosphonoacetate on Marek's disease virus replication
Journal of the National Cancer Institute
|April 1, 1976
Summary
Phosphonoacetate (PA) effectively inhibited avian herpesvirus replication and DNA synthesis in cell cultures. However, PA did not inhibit Marek
Area of Science:
- Virology
- Molecular Biology
- Biochemistry
Background:
- Avian herpesviruses, such as Marek's disease virus (MDV), pose significant threats to poultry health.
- Developing effective antiviral agents against these viruses is crucial for the poultry industry.
Purpose of the Study:
- To investigate the antiviral activity of phosphonoacetate (PA) and its analogues against avian herpesviruses.
- To determine the effect of PA on viral DNA synthesis and host DNA polymerases.
Main Methods:
- Cell culture experiments were performed to assess viral replication inhibition.
- Enzyme assays were conducted to measure the inhibition of viral and host DNA polymerases.
- In vivo studies in chickens were performed to evaluate PA's efficacy against MDV.
Main Results:
- Phosphonoacetate (PA) completely inhibited the replication of MDV, herpesvirus of turkeys, and owl herpesvirus in cell cultures at 100 µg/ml.
- PA demonstrated significant inhibition of viral DNA polymerases (50% inhibition at 0.2 µg/ml) and host alpha DNA polymerase.
- PA did not inhibit MDV replication or prevent lymphoma development when administered to chickens.
Conclusions:
- Phosphonoacetate (PA) is a potent inhibitor of avian herpesvirus replication and viral DNA synthesis in vitro.
- PA's mechanism involves the inhibition of viral and host DNA polymerases.
- PA lacks in vivo efficacy against MDV in chickens, suggesting limitations for therapeutic applications.
Related Concept Videos
Lytic Cycle of Bacteriophages
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the lytic replication...
Rabies
Rabies is a lethal zoonotic disease caused by a single-stranded, negative-sense RNA virus of the Lyssavirus genus, within the family Rhabdoviridae. Its primary mode of transmission to humans is through bites or saliva-contaminated scratches from infected mammals such as dogs, bats, raccoons, or foxes. Transmission can also occur if infectious saliva contacts abraded skin or intact mucous membranes, including the conjunctiva.Viral Entry and Early ReplicationOnce introduced at the bite or scratch...
Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...

